戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 279作成日:2026年10月23日

4-Bromophenol → 4-Morpholinophenol

https://huagongshe.com/ja/reaction/279

反応式

関与物質

役割名称HCID仕込み量
反応物4-BromophenolHCID 7808—
反応物MorpholineHCID 8083—
試薬Sodium t-butoxideHCID 23676156—
触媒Bis(dibenzylideneacetone)palladiumHCID 9811564—
触媒2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 11155794—
溶媒TolueneHCID 1140—
生成物4-MorpholinophenolHCID 8051031.25%

反応条件

温度100 °C

反応手順

4-Bromophenol (865 mg, 5 mmol), Tris(dibenzylideneacetone)dipalladium(0) (229 mg, 0.25 mmol), 2-Dicyclohexylphosphino-2',4',6'-tri-iso-propyl-1,1'-biphenyl (238 mg, 0.50 mmol), Morpholine (0.437 mL, 5.00 mmol) and sodium tert-butoxide (1009 mg, 10.50 mmol) were stirred in toluene (5 mL) overnight at 100 °C. The mixture was allowed to cool to ambient temperature. Ethylacetate was added and the mixture was washed with aqueous NaHCO3 (satd.) and water. The organic phase was separated, dried over MgSO4, filtered and the solvent removed by rotary evaporation. The crude product was added to a silica gel column and was eluted with 0-2 % MeOH in DCM. The collected fraction were combined and the solvent was removed by rotary evaporation. 1H NMR in CDCl3 is consistent with desired product MS (m+1) = 180. HPLC Peak RT = 2.55 minutes is product. Purity = 96%.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-c3c3446fa521406ab3b5349b3ab1378a
出典メモ750 AstraZeneca ELN dataset